跳至主要内容
临床试验/NCT02323997
NCT02323997已完成不适用

Human Papillomavirus-Associated Cervical Neoplasia in Switzerland at the Start of a National Vaccination Programme: Crosssectional Study

University of Bern10 个研究点 分布在 1 个国家目标入组 767 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
767
试验地点
10
主要终点
Human papillomavirus presence and type

研究概览

简要总结

This study will investigate the types of HPV in samples from women with cervical pre-cancer and cancer and gather information to help investigate the impact of HPV vaccination in Switzerland.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Participant is willing and able to give informed consent for participation in the study.
  • Participant is literate in German, French, Italian or English.
  • Female, aged 18 years or above.
  • Histologically confirmed CIN3+ lesions, i.e. CIN3, adenocarcinoma in situ and invasive carcinoma of the cervix.
  • Participant resides in the canton Zurich, Geneva, Basel, Baselland, Luzern or Ticino.

排除标准

  • 未提供

结局指标

主要结局

Human papillomavirus presence and type

时间窗: 2 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验

Human Papillomavirus in Cervical Cancer and... | 临床试验